Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

39.99
-1.1850-2.88%
Volume:7.85M
Turnover:314.77M
Market Cap:177.50B
PE:11.04
High:40.78
Open:40.76
Low:39.70
Close:41.17
52wk High:81.44
52wk Low:35.12
Shares:4.44B
Float Shares:3.19B
Volume Ratio:1.35
T/O Rate:0.25%
Dividend:1.72
Dividend Rate:4.31%
EPS(TTM):3.62
EPS(LYR):3.62
ROE:60.70%
ROA:17.43%
PB:6.22
PE(LYR):11.04

Loading ...

Earning Preview: Novo-Nordisk A/S revenue expected to decrease by 4.40%, institutional views are neutral

Earnings Agent
·
5 hours ago

Health Canada approves first generic version of Novo Nordisk’s Ozempic

Bloomberg
·
17 hours ago

Novo Nordisk’s Oral Ozempic And Pediatric Plans Reframe GLP-1 Opportunity

Simply Wall St.
·
18 hours ago

Biotech Firm Hemab Therapeutics Sets US IPO Target at Up to $212 Million

Stock News
·
Yesterday

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Yesterday

Novo Nordisk Updates on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Apr 27

Novo Nordisk Weight-Loss Pill Prescriptions to Drive Near-Term Share Price -- Market Talk

Dow Jones
·
Apr 27

Novo Nordisk Tracks Real‑World Refixia® Use In Japan: What Investors Should Watch

TIPRANKS
·
Apr 26

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Stock News
·
Apr 25

Eli Lilly's Oral Weight-Loss Drug Shows Tepid Prescription Growth in Second Week

Deep News
·
Apr 25

Moderately bullish activity in Novo Nordisk with shares up 6.37%

TIPRANKS
·
Apr 25

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
Apr 25

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live
·
Apr 24

Eli Lilly Shares Decline Over 4% While Novo Nordisk Rises 6%

Deep News
·
Apr 24

Novo Shares Rise 6% While Lilly Falls over 4%. Lilly's New Obesity Pill Off to Slow Start in Race With Novo

Tiger Newspress
·
Apr 24

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Apr 24

Stock Track | Novo Nordisk Soars 5.01% Intraday on Positive Pediatric Trial Results and Strong Oral Drug Performance

Stock Track
·
Apr 24

Eli Lilly Stumbles in Oral Weight-Loss Drug Race as Novo Nordisk Takes Early Lead

Deep News
·
Apr 24

Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children

Benzinga_recent_news
·
Apr 24

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
Apr 24